Ala Covali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ala Covali has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Emilie Bequignon
Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France
2 shared publications - Guillaume Cathelain
Mitral (Apneal), Paris, France
2 shared publications - Juliette Millet
Mitral (Apneal), Paris, France
2 shared publications - Justine Frija-Masson
Service de Physiologie ‐Explorations Fonctionnelles, Hôpital Bichat, Assistance Publique ‐ Hôpitaux de Paris, Paris, France
2 shared publications - Marie Pia D'ORtho
Service de Physiologie ‐Explorations Fonctionnelles, Hôpital Bichat, Assistance Publique ‐ Hôpitaux de Paris, Paris, France
2 shared publications - Pierre Alexis Geoffroy
Inserm U1141, Université de Paris, NeuroDiderot Paris France
2 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluation of the Clinical Performance of a Chest-Worn Smartphone-based Medical Device for Sleep Apnea-Hypopnea Syndrome Diagnosis: The EASY Study
Background: Systems that record sounds and inertial signals from a smartphone placed on the thorax have the potential to increase access to sleep-apnoea diagnosis, but evaluations against polysomnography (PSG) are lacking. The EASY study evaluated the diagnostic performance of Apneal®, a smartphone Software as a Medical Device, to estimate the apnea–hypopnea index (AHI) and detect clinically relevant AHI thresholds compared with PSG.Methods: Prospective, multicentre clinical study in nine European sleep centres. Adults referred for diagnostic overnight PSG had in-lab PSG (central scoring) and simultaneous Apneal® v1.0.0 with Apneal® AI v1.3.1 recording with a consumer smartphone secured to the chest using an adhesive band. The primary objective was diagnostic performance at AHI thresholds (≥5, ≥15, ≥30 events/hour) versus PSG ; secondary objectives included continuous AHI agreement, comparison to polygraphy and nocturnal oximetry. The statistical analysis plan was prespecified; main diagnostic metrics reported are sensitivity, specificity, positive and negative predictive values (PPV, NPV), and area under the ROC curve (AUC) with 95% CIs.Findings: 491 participants were enrolled, and 432 analyzed. Apneal® severity classification versus adjudicated PSG had a quadratic-weighted κ = 0.88 (95% CI 0.83–0.92). At prespecified binary thresholds: for AHI ≥5 sensitivity 97% (95% CI 95–98), specificity 78% (61–89), PPV 98% (96–99), NPV 70% (54–83); for AHI ≥15 sensitivity 91% (87–94), specificity 91% (85–94), PPV 93% (89–96), NPV 88% (82–92); for AHI ≥30 sensitivity 84% (77–90), specificity 95% (92–97), PPV 88% (81–93), NPV 94% (90–96).Interpretation: Apneal® — a smartphone placed on the thorax and processed by a locked AI pipeline — provided accurate AHI estimates and high discrimination for clinically relevant thresholds compared with adjudicated PSG in a large, multicentre, real-world population. Performance was robust across the spectrum of severity.
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of the Clinical Performance of a Chest-Worn Smartphone-based Medical Device for Sleep Apnea-Hypopnea Syndrome Diagnosis: The EASY Study
Background: Systems that record sounds and inertial signals from a smartphone placed on the thorax have the potential to increase access to sleep-apnoea diagnosis, but evaluations against polysomnography (PSG) are lacking. The EASY study evaluated the diagnostic performance of Apneal®, a smartphone Software as a Medical Device, to estimate the apnea–hypopnea index (AHI) and detect clinically relevant AHI thresholds compared with PSG.Methods: Prospective, multicentre clinical study in nine European sleep centres. Adults referred for diagnostic overnight PSG had in-lab PSG (central scoring) and simultaneous Apneal® v1.0.0 with Apneal® AI v1.3.1 recording with a consumer smartphone secured to the chest using an adhesive band. The primary objective was diagnostic performance at AHI thresholds (≥5, ≥15, ≥30 events/hour) versus PSG ; secondary objectives included continuous AHI agreement, comparison to polygraphy and nocturnal oximetry. The statistical analysis plan was prespecified; main diagnostic metrics reported are sensitivity, specificity, positive and negative predictive values (PPV, NPV), and area under the ROC curve (AUC) with 95% CIs.Findings: 491 participants were enrolled, and 432 analyzed. Apneal® severity classification versus adjudicated PSG had a quadratic-weighted κ = 0.88 (95% CI 0.83–0.92). At prespecified binary thresholds: for AHI ≥5 sensitivity 97% (95% CI 95–98), specificity 78% (61–89), PPV 98% (96–99), NPV 70% (54–83); for AHI ≥15 sensitivity 91% (87–94), specificity 91% (85–94), PPV 93% (89–96), NPV 88% (82–92); for AHI ≥30 sensitivity 84% (77–90), specificity 95% (92–97), PPV 88% (81–93), NPV 94% (90–96).Interpretation: Apneal® — a smartphone placed on the thorax and processed by a locked AI pipeline — provided accurate AHI estimates and high discrimination for clinically relevant thresholds compared with adjudicated PSG in a large, multicentre, real-world population. Performance was robust across the spectrum of severity.
- Open Access
- 5 September 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (5) , 1-12
Proposition of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity
Purpose obstructive sleep apnea is underdiagnosed due to limited access to polysomnography (PSG). We aimed to assess the performances of Apneal®, an application recording sound and movements thanks to a smartphone’s microphone, accelerometer and gyroscope, to estimate patients’ apnea-hypopnea index (AHI). Methods monocentric proof-of-concept study with a first manual scoring step, then automatic detection of respiratory events from recorded signals using a sequential deep-learning model (version 0.1 of Apneal® automatic scoring of respiratory events, end 2022), in adult patients. Results 46 patients (women 34%, BMI 28.7 kg/m²) were included. Sensitivity of manual scoring was 0.91 (95% CI [0.8-1]) for IAH > 15 and 0.85 [0.67-1] for AHI > 30, and positive predictive values (PPV) 0.89 [0.76–0.97] and 0.94 [0.8-1]. We obtained an AUC-ROC of 0.85 (95% CI [0.69–0.96]) and AUC-PR of 0.94 (95% CI [0.84–0.99]) for the identification of AHI > 15, and AUC-ROC of 0.95 [0.860.99] and AUC-PR of 0.93 [0.81–0.99] for AHI > 30. The ICC between the AHI estimated manually, and from the PSG is 0.89 (p = 6.7 × 10− 17), Pearson correlation 0.90 (p = 1.25 × 10− 17). Automatic scoring found sensitivity of 1 [0.95-1], PPV of 0.9 [0.8–0.9] for AHI > 15, and sensitivity 0.95 [0.84-1], PPV 0.69 [0.52–0.85] for AHI > 30. The ICC between the estimated AHI, and PSG scorings is 0.84 (p = 5.4 × 10− 11) and Pearson correlation is 0.87 (p = 1.7 × 10− 12). Conclusion Manual scoring of smartphone-based signals is possible and accurate compared to PSG-based scorings. Automatic scoring method based on a deep learning model provides promising results. Trial registration NCT03803098.
- 5 September 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (5) , 1-12
Open AccessProposition of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity
Purpose obstructive sleep apnea is underdiagnosed due to limited access to polysomnography (PSG). We aimed to assess the performances of Apneal®, an application recording sound and movements thanks to a smartphone’s microphone, accelerometer and gyroscope, to estimate patients’ apnea-hypopnea index (AHI). Methods monocentric proof-of-concept study with a first manual scoring step, then automatic detection of respiratory events from recorded signals using a sequential deep-learning model (version 0.1 of Apneal® automatic scoring of respiratory events, end 2022), in adult patients. Results 46 patients (women 34%, BMI 28.7 kg/m²) were included. Sensitivity of manual scoring was 0.91 (95% CI [0.8-1]) for IAH > 15 and 0.85 [0.67-1] for AHI > 30, and positive predictive values (PPV) 0.89 [0.76–0.97] and 0.94 [0.8-1]. We obtained an AUC-ROC of 0.85 (95% CI [0.69–0.96]) and AUC-PR of 0.94 (95% CI [0.84–0.99]) for the identification of AHI > 15, and AUC-ROC of 0.95 [0.860.99] and AUC-PR of 0.93 [0.81–0.99] for AHI > 30. The ICC between the AHI estimated manually, and from the PSG is 0.89 (p = 6.7 × 10− 17), Pearson correlation 0.90 (p = 1.25 × 10− 17). Automatic scoring found sensitivity of 1 [0.95-1], PPV of 0.9 [0.8–0.9] for AHI > 15, and sensitivity 0.95 [0.84-1], PPV 0.69 [0.52–0.85] for AHI > 30. The ICC between the estimated AHI, and PSG scorings is 0.84 (p = 5.4 × 10− 11) and Pearson correlation is 0.87 (p = 1.7 × 10− 12). Conclusion Manual scoring of smartphone-based signals is possible and accurate compared to PSG-based scorings. Automatic scoring method based on a deep learning model provides promising results. Trial registration NCT03803098.